Cargando…

Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue

BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disease characterized by selective degeneration of dopaminergic neurons in the substantia nigra (SN). The familial form of PD, PARK2, is caused by mutations in the parkin gene. parkin-knockout mouse models show some abnormalities, but they...

Descripción completa

Detalles Bibliográficos
Autores principales: Imaizumi, Yoichi, Okada, Yohei, Akamatsu, Wado, Koike, Masato, Kuzumaki, Naoko, Hayakawa, Hideki, Nihira, Tomoko, Kobayashi, Tetsuro, Ohyama, Manabu, Sato, Shigeto, Takanashi, Masashi, Funayama, Manabu, Hirayama, Akiyoshi, Soga, Tomoyoshi, Hishiki, Takako, Suematsu, Makoto, Yagi, Takuya, Ito, Daisuke, Kosakai, Arifumi, Hayashi, Kozo, Shouji, Masanobu, Nakanishi, Atsushi, Suzuki, Norihiro, Mizuno, Yoshikuni, Mizushima, Noboru, Amagai, Masayuki, Uchiyama, Yasuo, Mochizuki, Hideki, Hattori, Nobutaka, Okano, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546866/
https://www.ncbi.nlm.nih.gov/pubmed/23039195
http://dx.doi.org/10.1186/1756-6606-5-35
_version_ 1782256123393343488
author Imaizumi, Yoichi
Okada, Yohei
Akamatsu, Wado
Koike, Masato
Kuzumaki, Naoko
Hayakawa, Hideki
Nihira, Tomoko
Kobayashi, Tetsuro
Ohyama, Manabu
Sato, Shigeto
Takanashi, Masashi
Funayama, Manabu
Hirayama, Akiyoshi
Soga, Tomoyoshi
Hishiki, Takako
Suematsu, Makoto
Yagi, Takuya
Ito, Daisuke
Kosakai, Arifumi
Hayashi, Kozo
Shouji, Masanobu
Nakanishi, Atsushi
Suzuki, Norihiro
Mizuno, Yoshikuni
Mizushima, Noboru
Amagai, Masayuki
Uchiyama, Yasuo
Mochizuki, Hideki
Hattori, Nobutaka
Okano, Hideyuki
author_facet Imaizumi, Yoichi
Okada, Yohei
Akamatsu, Wado
Koike, Masato
Kuzumaki, Naoko
Hayakawa, Hideki
Nihira, Tomoko
Kobayashi, Tetsuro
Ohyama, Manabu
Sato, Shigeto
Takanashi, Masashi
Funayama, Manabu
Hirayama, Akiyoshi
Soga, Tomoyoshi
Hishiki, Takako
Suematsu, Makoto
Yagi, Takuya
Ito, Daisuke
Kosakai, Arifumi
Hayashi, Kozo
Shouji, Masanobu
Nakanishi, Atsushi
Suzuki, Norihiro
Mizuno, Yoshikuni
Mizushima, Noboru
Amagai, Masayuki
Uchiyama, Yasuo
Mochizuki, Hideki
Hattori, Nobutaka
Okano, Hideyuki
author_sort Imaizumi, Yoichi
collection PubMed
description BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disease characterized by selective degeneration of dopaminergic neurons in the substantia nigra (SN). The familial form of PD, PARK2, is caused by mutations in the parkin gene. parkin-knockout mouse models show some abnormalities, but they do not fully recapitulate the pathophysiology of human PARK2. RESULTS: Here, we generated induced pluripotent stem cells (iPSCs) from two PARK2 patients. PARK2 iPSC-derived neurons showed increased oxidative stress and enhanced activity of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. iPSC-derived neurons, but not fibroblasts or iPSCs, exhibited abnormal mitochondrial morphology and impaired mitochondrial homeostasis. Although PARK2 patients rarely exhibit Lewy body (LB) formation with an accumulation of α-synuclein, α-synuclein accumulation was observed in the postmortem brain of one of the donor patients. This accumulation was also seen in the iPSC-derived neurons in the same patient. CONCLUSIONS: Thus, pathogenic changes in the brain of a PARK2 patient were recapitulated using iPSC technology. These novel findings reveal mechanistic insights into the onset of PARK2 and identify novel targets for drug screening and potential modified therapies for PD.
format Online
Article
Text
id pubmed-3546866
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35468662013-01-17 Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue Imaizumi, Yoichi Okada, Yohei Akamatsu, Wado Koike, Masato Kuzumaki, Naoko Hayakawa, Hideki Nihira, Tomoko Kobayashi, Tetsuro Ohyama, Manabu Sato, Shigeto Takanashi, Masashi Funayama, Manabu Hirayama, Akiyoshi Soga, Tomoyoshi Hishiki, Takako Suematsu, Makoto Yagi, Takuya Ito, Daisuke Kosakai, Arifumi Hayashi, Kozo Shouji, Masanobu Nakanishi, Atsushi Suzuki, Norihiro Mizuno, Yoshikuni Mizushima, Noboru Amagai, Masayuki Uchiyama, Yasuo Mochizuki, Hideki Hattori, Nobutaka Okano, Hideyuki Mol Brain Research BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disease characterized by selective degeneration of dopaminergic neurons in the substantia nigra (SN). The familial form of PD, PARK2, is caused by mutations in the parkin gene. parkin-knockout mouse models show some abnormalities, but they do not fully recapitulate the pathophysiology of human PARK2. RESULTS: Here, we generated induced pluripotent stem cells (iPSCs) from two PARK2 patients. PARK2 iPSC-derived neurons showed increased oxidative stress and enhanced activity of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. iPSC-derived neurons, but not fibroblasts or iPSCs, exhibited abnormal mitochondrial morphology and impaired mitochondrial homeostasis. Although PARK2 patients rarely exhibit Lewy body (LB) formation with an accumulation of α-synuclein, α-synuclein accumulation was observed in the postmortem brain of one of the donor patients. This accumulation was also seen in the iPSC-derived neurons in the same patient. CONCLUSIONS: Thus, pathogenic changes in the brain of a PARK2 patient were recapitulated using iPSC technology. These novel findings reveal mechanistic insights into the onset of PARK2 and identify novel targets for drug screening and potential modified therapies for PD. BioMed Central 2012-10-06 /pmc/articles/PMC3546866/ /pubmed/23039195 http://dx.doi.org/10.1186/1756-6606-5-35 Text en Copyright ©2012 Imaizumi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Imaizumi, Yoichi
Okada, Yohei
Akamatsu, Wado
Koike, Masato
Kuzumaki, Naoko
Hayakawa, Hideki
Nihira, Tomoko
Kobayashi, Tetsuro
Ohyama, Manabu
Sato, Shigeto
Takanashi, Masashi
Funayama, Manabu
Hirayama, Akiyoshi
Soga, Tomoyoshi
Hishiki, Takako
Suematsu, Makoto
Yagi, Takuya
Ito, Daisuke
Kosakai, Arifumi
Hayashi, Kozo
Shouji, Masanobu
Nakanishi, Atsushi
Suzuki, Norihiro
Mizuno, Yoshikuni
Mizushima, Noboru
Amagai, Masayuki
Uchiyama, Yasuo
Mochizuki, Hideki
Hattori, Nobutaka
Okano, Hideyuki
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
title Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
title_full Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
title_fullStr Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
title_full_unstemmed Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
title_short Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
title_sort mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in park2 ipsc-derived neurons and postmortem brain tissue
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546866/
https://www.ncbi.nlm.nih.gov/pubmed/23039195
http://dx.doi.org/10.1186/1756-6606-5-35
work_keys_str_mv AT imaizumiyoichi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT okadayohei mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT akamatsuwado mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT koikemasato mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT kuzumakinaoko mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT hayakawahideki mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT nihiratomoko mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT kobayashitetsuro mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT ohyamamanabu mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT satoshigeto mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT takanashimasashi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT funayamamanabu mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT hirayamaakiyoshi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT sogatomoyoshi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT hishikitakako mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT suematsumakoto mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT yagitakuya mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT itodaisuke mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT kosakaiarifumi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT hayashikozo mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT shoujimasanobu mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT nakanishiatsushi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT suzukinorihiro mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT mizunoyoshikuni mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT mizushimanoboru mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT amagaimasayuki mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT uchiyamayasuo mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT mochizukihideki mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT hattorinobutaka mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue
AT okanohideyuki mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue